dockets: FDA-2026-N-0707

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id
FDA-2026-N-0707 FDA GlaxoSmithKline; Withdrawal of Approval of a New Drug Application for Wellcovorin (leucovorin calcium) tablets, EQ 5 mg base and EQ 25 mg base Nonrulemaking 2026-04-10T13:40:29Z 0b000064b917b332

Links from other tables